ObsEva Announces Enrollment Completion of Linzagolix Phase 3 EDELWEISS 3 Trial for Patients with Moderate to Severe Endometriosis-Associated Pain
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
ObsEva Announces Enrollment Completion of Linzagolix Phase 3 EDELWEISS 3 Trial for Patients with Moderate to Severe Endometriosis-Associated Pain
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Calliditas promotes Andrew Udell to President, North America
News provided by
Share this article
Calliditas Therapeutics AB (Nasdaq: CALT)
(Nasdaq Stockholm: CALTX)
( Calliditas ) today announced that former Head of North America Commercial, Andrew Udell, has been promoted to President, North America, effective immediately. Andrew has been instrumental in the growth of the US operations over the last 12 months and has done a great job of creating a strong connection between the US and European teams throughout this period of high growth. He is an experienced leader, and I am delighted to continue to work with him in this new role, said CEO Renee Aguiar-Lucander.
Share this article
Share this article
PETAH-TIKVA, Israel, May 3, 2021 /PRNewswire/ Global-e Online Ltd. ( Global-e ), the world s leading platform to enable and accelerate global, direct-to-consumer cross-border e-commerce, today announced that it has commenced the initial public offering of 15,000,000 of its ordinary shares. In addition, Global-e expects to grant the underwriters a 30-day option to purchase up to an additional 2,250,000 ordinary shares at the initial public offering price, less underwriting discounts and commissions. The initial public offering price is expected to be between $23 and $25 per share. Global-e has applied to list its ordinary shares on the Nasdaq Global Select Market under the ticker symbol GLBE .